Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 85: 967-972, 1998;
8750-7587/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barros, R. C. H.
Right arrow Articles by Branco, L. G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barros, R. C. H.
Right arrow Articles by Branco, L. G. S.
Vol. 85, Issue 3, 967-972, September 1998

Effect of nitric oxide synthase inhibition on hypercapnia-induced hypothermia and hyperventilation

Renata C. H. Barros and Luiz G. S. Branco

Departamentos de Fisiologia, Faculdade de Odontologia de Ribeirão Preto and Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14040-904 Ribeirão Preto, São Paulo, Brazil

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Hypercapnia elicits hypothermia in a number of vertebrates, but the mechanisms involved are not well understood. In the present study, we assessed the participation of the nitric oxide (NO) pathway in hypercapnia-induced hypothermia and hyperventilation by means of NO synthase inhibition by using Nomega -nitro-L-arginine (L-NNA). Measurements of ventilation, body temperature, and oxygen consumption were performed in awake unrestrained rats before and after L-NNA injection (intraperitoneally) and L-NNA injection followed by hypercapnia (5% CO2). Control animals received saline injections. L-NNA altered the breathing pattern during the control situation but not during hypercapnia. A significant (P < 0.05) drop in body temperature was measured after both L-NNA (40 mg/kg) and 5% inspired CO2, with a drop in oxygen consumption in the first situation but not in the second. Hypercapnia had no effect on L-NNA-induced hypothermia. The ventilatory response to hypercapnia was not changed by L-NNA, even though L-NNA caused a drop in body temperature. The present data indicate that the two responses elicited by hypercapnia, i.e., hyperventilation and hypothermia, do not share NO as a common mediator. However, the L-arginine-NO pathway participates, although in an unrelated way, in respiratory function and thermoregulation.

body temperature; ventilation; carbon dioxide

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

A REDUCTION IN BODY TEMPERATURE (Tb) is generally observed when an animal encounters stress such as hypoxia (36) and hypercapnia (5). Although this response is extremely widespread among taxa (5), little is known about the potential mediators of hypothermia and also about the effect of Tb on the hypercapnic drive to breathe.

The endothelium-derived relaxing factor, which has been definitively identified as nitric oxide (NO) (23), has started a revolution in the understanding of several mammalian systems since its description in 1980 by Furchgott and Zawadzki (9). NO is an active regulatory molecule at the periphery (23) and also serves as a neuronal messenger in the brain (18). It is synthesized from L-arginine, and the enzyme responsible for this synthesis is NO synthase (NOS). L-arginine analogs such as Nomega -nitro-L-arginine (L-NNA) have been used as inhibitors of NO synthesis. Compared with other analogs, L-NNA crosses the blood-brain barrier relatively easily and strongly inhibits NOS in the central nervous system (cf. Ref. 34).

It has become increasingly clear that NO may play a role in ventilatory (12) and Tb (3) control in mammals. NOS is present in medullary and pontine respiratory regions (8), where a central respiratory neural network involving NO may exist. At the periphery, NO acts as an inhibitory transmitter in the carotid bodies (6). As to its temperature effects, NO plays a role in thermoregulation during exercise in horses (22) and acts as an endogenous antipyretic factor in endotoxin-induced fever in rabbits (11). Recently, it has been shown that NO participates in hypoxia-induced hypothermia (3).

No reports are available about the effect of NOS inhibition on hypercapnia-induced hyperventilation and hypothermia. Branco and Wood (5) demonstrated that hypercapnia causes behavioral hypothermia in the toad Bufo marinus and that this response is mediated by central chemoreceptors, i.e., at the same site where hypercapnia elicits hyperventilation not only in amphibians (4) but also in mammals (29). Because both responses to CO2 inhalation may share to some extent the same central sensor, they may also share some mediators, and NO seems to be a strong candidate. The purpose of the present study was to examine the role of the L-arginine-NO pathway in the hyperventilatory and hypothermic responses to CO2 inhalation of conscious rats.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Animals

Experiments were performed in awake adult male Wistar rats (Rattus norvegicus; Rodentia: Muridae), weighing 230- 300 g, housed under conditions of controlled temperature [25 ± 2 (SD) °C], and exposed to a daily 12:12-h light-dark cycle. The animals were allowed free access to water and food. The rats used in this study were divided into two groups, an experimental group treated with a NOS blocker (L-NNA) and a control group (n = 8 rats) injected with saline. The experimental group was divided into three subgroups (n = 8 rats/subgroup), according to the NOS-blocker dose used.

Ventilation (VE) Measurements

Measurements of VE were performed by the body plethysmograph method (2). The animal was placed in a Plexiglas chamber (5 liters) and allowed to move about freely while the chamber was flushed with humidified air or a normoxic hypercapnic gas mixture of 5% CO2. Each time VE was measured, the flow was interrupted and the chamber was sealed for short periods of time (no more than 3 min), and the oscillations in air temperature caused by breathing could be measured as pressure oscillations. This procedure was performed once per experimental condition. Calibration for volume was obtained during each measurement by injecting the chamber with a known amount of air (0.2 ml) by using a graduated syringe. Signals from a differential air transducer displayed on a paper recorder (Hewlett-Packard) allowed the calculation of respiratory frequency (f) and tidal volume (VT) by appropriate correction factors (20).

Tb Measurements

Tb was determined by inserting a thermocouple probe into the colon of the animals every time a Tb measurement was made. Before the experiments, the rats were habituated to temperature measurements, which were performed quickly to avoid any stress-induced elevations in Tb.

O2 Consumption (VO2) Measurements

VO2 was measured by using an O2 analyzer (Saylor Servomex, type OA. 272) in a closed-flow system. Animals were placed in the same 5-liter Plexiglas chamber ventilated with humidified air or a normoxic hypercapnic gas mixture of 5% CO2. At the end of the control or experimental period, the flow was interrupted to perform the measurements. The chamber was then totally sealed, and six samples of chamber air (30 ml) were taken at 3-min intervals and passed through the O2 analyzer. Therefore, the chamber remained sealed for 15 min in each condition. This period was needed to collect sufficient data to ensure good accuracy of the slopes. A curve of %O2 evolution was constructed, and its slope was given the value of VO2. Because we obtained resting VO2 values agreeing with data in the literature, we concluded that this method was acceptable.

Experimental Protocols

Experiment 1: Measurements of VE and Tb. Each animal was placed in the chamber flushed with room air. After the animals remained calm (at least 30 min), control Tb and then VE were measured. Subsequently, experimental rats were treated with L-NNA (Sigma Chemical) by intraperitoneal bolus injection of 10, 20, or 40 mg/kg body weight, and control rats were treated with the same volume of saline (150 mM NaCl). Two hours after L-NNA or saline administration, measurements of Tb and VE were obtained. Subsequently, a normoxic hypercapnic gas mixture of 5% CO2 (AGA) was flushed through the chamber for 30 min. At the end of the experiment, VE and Tb were measured again. Saline was the vehicle in which L-NNA was dissolved. The volume of each injection was 0.5 ml.

Experiment 2: Measurements of VO2. Animals were placed in the chamber ventilated with room air for at least 30 min until they remained quiet, and the basal VO2 was measured. The three subgroups of rats received an intraperitoneal bolus injection of 10, 20, or 40 mg/kg body weight of L-NNA, and the control group received an intraperitonial injection of saline, and VO2 was measured 2 h later. Subsequently, a normoxic hypercapnic gas mixture of 5% CO2 was flushed through the chamber for 30 min, and VO2 was measured again.

Statistical Analysis

Values are reported as means ± SE (unless otherwise stated). The effect of saline or L-NNA injection on VE, VT, f, Tb, and VO2 was evaluated by using one-way ANOVA. The Tukey-Kramer multiple-comparisons test (VE, VT, f, and Tb) and the Kruskal-Wallis test (VO2) were applied as post hoc tests. Point-by-point comparisons of mean values before and after hypercapnia were performed by Student's t-test. Values of P < 0.05 were considered to be significant.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

During the two sets of experiments, the mean chamber temperature was 25.81 ± 0.69 (SD) °C, and room temperature was 24.62 ± 0.76°C. Individual values of VE, Tb, and VO2 during air breathing and before any injection ranged from 601.6 to 965.86 ml BTPS · min-1 · kg-1, from 36.10 to 36.70°C, and from 14.84 to 24.12 ml STPD · min-1 · kg-1, respectively, and no group differed significantly from the saline group in baseline values.

Experiment 1

Figure 1 shows the pulmonary VE recordings obtained after saline or L-NNA injections during air or 5% CO2 breathing. Animals treated with the NOS blocker had a ventilatory response during air breathing that consisted of episodes of many breaths separated by episodes of few breaths. This response was dose dependent but not evenly distributed: 25, 50, and 62.5% of the animals treated with 10, 20, and 40 mg/kg, respectively, showed this changed ventilatory pattern, whereas no rat injected with saline was affected. No difference in animal behavior was observed between control and treated groups. The breathing pattern was recovered during CO2 inhalation, when both groups, experimental and control, showed similar recordings.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Ventilation recordings of rats illustrating effect of peripheral injection of saline (A) or Nomega -nitro-L-arginine (L-NNA) at doses of 10 (B), 20 (C), and 40 (D) mg/kg during air and 5% CO2 inhalation.

The NOS blockade tended to elicit a drop in f because of the episodes of few breaths, but during the periods of many breaths both f and VT tended to be higher compared with control animals. As a result, the NOS blockade tended to increase VE in a dose-dependent way, but this elevation was not significant (P > 0.05; 1-way ANOVA). Hypercapnia caused similar increases (P < 0.05; paired t-test) in VE in both the L-NNA and saline groups (Table 1). Although VE increases 226% with 40 mg/kg L-NNA and 178% with 20 mg/kg L-NNA, this difference is not significant (P = 0.1166; unpaired t-test).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effect of peripheral injection of L-NNA and saline on VE, VT, and f in rats during hypercapnia

Figure 2 illustrates the effect of the NOS blocker on Tb during air or 5% CO2 breathing. When saline was injected intraperitoneally, no change in Tb was observed. Conversely, L-NNA injected at the 40 mg/kg dose elicited a significant reduction in Tb (P < 0.05; 1-way ANOVA) of 0.74 ± 0.05°C, whereas 10 and 20 mg/kg L-NNA caused no significant change. The changes in Tb caused by NOS blockade were not altered by hypercapnia. When inspired CO2 was increased from 0 to 5%, a significant (P < 0.05; paired t-test) decrease in Tb was observed in the saline group.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of peripheral injection of L-NNA at 10, 20, and 40 mg/kg body wt (bullet ) or saline (open circle ) on body temperature during hypercapnia. Values are means ± SE (n = 8 rats/group). * Significantly different mean values before and after L-NNA injections (P < 0.05; 1-way ANOVA). + Significant difference in mean values before and after 30 min of 5% CO2 exposure (P < 0.05; paired t-test).

Experiment 2

The individual curves of %O2 evolution showed accurate slopes, i.e., maximum changes observed were <5%. Figure 3 shows the effect of L-NNA on VO2 during air or 5% CO2 breathing. VO2 was significantly reduced (P < 0.05; 1-way ANOVA) 2 h after injection of 40 mg/kg of the NOS blocker. The lower doses tended to decrease VO2, but the differences were not significant. Hypercapnia had no effect on VO2 in the animals injected with saline and 10 and 20 mg/kg of L-NNA (P > 0.05; paired t-test), whereas in the animals injected with 40 mg/kg of L-NNA, the low VO2 was recovered during exposure to 5% CO2.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of peripheral injection of L-NNA at 10, 20, and 40 mg/kg body wt (bullet ) or saline (open circle ) on O2 consumption (VO2) during hypercapnia. Values are means ± SE (n = 7 rats/group). * Significant difference in mean values before and after L-NNA injections (P < 0.05; 1-way ANOVA).

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Teppema et al. (34) have recently addressed the effects of NOS inhibition on the peripheral and central chemoreflex loops during hypercapnia in anesthetized cats with clamped Tb. The present study provides evidence that the significant drop of 0.74 ± 0.05°C in Tb caused by NOS blockade has no effect on the hypercapnic drive to breathe in awake rats. As to Tb regulation, both hypercapnia and NOS inhibition are known to cause hypothermia, and we now show that the combination of these two stimuli is not additive because hypercapnia caused no further drop in Tb of the animals previously treated with L-NNA, indicating a possible link between the mechanisms of the two stimuli.

The basal values of VE (2), Tb (24), and VO2 (2) measured in the present study support previously reported data. As in other studies with rats, hypercapnia caused hyperventilation (1, 10), hypothermia (1, 10), and no change in VO2 (1, 31) in the control situation.

Effects of L-NNA and Hypercapnia on VE

The sites of action of L-NNA that may affect respiratory function are distributed throughout the body. At the periphery, NO acts as an inhibitory neurotransmitter in the carotid body (6) and alters arterial blood pressure, which can change VE probably by a baroreceptor-mediated effect (cf. Ref. 34). NO is linked to glutamatergic neurotransmission in the central nervous system (27, 34), and activation of glutamate receptors in the nucleus tractus solitarii and paragigantocellular nucleus is necessary to maintain normal levels of VE and also for a normal ventilatory CO2 response to occur (26). It has been demonstrated that NO enhances the excitability and spontaneous discharge rates of neurons in the nucleus tractus solitarii (19) and that L-NNA produces a disruption of the pneumotaxic mechanism (18).

In the present study we found an unusual ventilatory pattern during air breathing 2 h after L-NNA injection. Because this response was totally unexpected and was not the purpose of the study, some information cannot be provided with the present protocol and remains to be investigated, such as the duration of the abnormal ventilatory pattern, the time course of the dose-dependent response, and the situation during normoxia after CO2 breathing. Although no difference in animal behavior was observed between control and treated groups, we should not exclude the possibility of a toxic effect of the drug. This seems to be unlikely because the L-NNA doses in this study and even higher ones have been regularly used without problems regarding toxic effects (34, 35). Thus we continue to think that the changes observed in the present study may be caused by a specific effect of the drug on NO. Because we used systemic administration of a NOS inhibitor, the atypical breathing pattern probably resulted from a balance between the peripheral and mainly the central systems where NO synthesis occurs. This affirmation is based on the facts that L-NNA crosses the blood-brain barrier (34) and that the altered ventilatory pattern, with episodes of many breaths separated by episodes of few breaths that we may call short nonventilatory periods, occurred in a dose-dependent way, but not after saline administration (Fig. 1). Episodic breathing is a pattern in many ectothermic vertebrates that can occur in some species of mammals in states normally associated with metabolic depression, such as hibernation and sleep (15). The lack of NO produced a fictive breathing pattern that resembled the episodic one and may support the argument that respiratory control is a system highly conserved in vertebrates. Furthermore, the present study indicates that NO plays a major role in normal respiratory function in rats.

Hypercapnia induced similar VE elevations in control and treated groups, which resulted from the same strategy, i.e., they were due to both VT and f increases. It seems that an additional factor (CO2) that stimulates the respiratory center can counterbalance the effect of L-NNA. Gozal et al. (12) also found that NOS inhibition, by using NG-nitro-L-arginine methyl ester and S-methyl-L-thiocitrulline injected intravenously, did not alter the overall ventilatory response to hypercapnia. However, changes in the ventilatory strategy consisting of VT decreases with parallel f increases were reported. These contrasting data suggest that different responses are likely to occur when different NOS blockers and different pathways of drug administration are compared. Although the mechanisms underlying these findings are unclear, NO does not seem to be important for chemosensitivity per se but may play a role in neurons underlying normal functions of respiratory timing and amplitude (19, 18).

Effects of L-NNA and Hypercapnia on Tb

The NO pathway participates in many systems that can interfere with Tb control, including brown adipose tissue (25), vascular smooth muscle (33), and some areas of the central nervous system, especially the hypothalamus (7). An interesting event is that treatment with L-NNA caused a reduction in Tb (Fig. 2) despite the fact that L-NNA should decrease cutaneous heat loss because it causes vasoconstriction in both large and small arteries (33). Most likely, L-NNA elicits hypothermia by reducing brown fat blood flow (25), which may result in a drop in the firing rate of sympathetic nerves innervating interscapular brown adipose tissue (7). Thus the available data indicate that L-NNA, at least when injected systemically, may induce a more pronounced decrease in heat production (25) compared with the reduction in heat loss (33).

A decrease in Tb during hypercapnia has often been observed in several species, ranging from amphibians (5) to mammals (31). The mechanisms responsible for hypothermia are not well understood (36). Available data indicate the existence of a number of modifiers, including NO, that act on the central nervous system for Tb control. Recently, the L-arginine-NO pathway in the central nervous system was shown to participate in hypoxia-induced hypothermia (3). We now report the involvement of NO in hypercapnia-induced hypothermia, which has been less studied than the hypothermia caused by hypoxia and seems to be more complex because it appears not to be associated with hypometabolism in rats. Lai et al. (17) showed that even when VO2 increases during hypercapnia, Tb consistently decreases by 1-1.5°C, a phenomenon that probably reflects the heat loss of hyperpnea and vasodilatation and is therefore likely to be related to the severity and duration of hypercapnia. However, these two effects of CO2 alone are not sufficient to explain a hypothermic response. Some studies indicate that hypercapnia-induced hypothermia may involve a central control. Indeed, Kuhnen et al. (16) reported a shift in the set point of Tb to a lower level during hypercapnia in the golden hamster, Mesocricetus auratus. In addition, the activity of neurons in the preoptic area, which affect Tb regulation, is higher during hypercapnia than during hypoxia in Wistar rats (32).

The present study confirms that hypercapnia-induced hypothermia may involve other mechanisms in addition to hyperventilation or vasodilatation because the drop caused by the NOS blockade was not changed by hypercapnia. The effect of CO2 inhalation on VE was maintained after treatment with L-NNA, but no additional decrease in Tb was observed, suggesting that hypercapnia-induced hypothermia has a central component that may involve the NO pathway.

Effects of L-NNA and Hypercapnia on VO2

It has been shown that NOS inhibitors produce hypothermia (3). Such a reduction in Tb may be accompanied by a decrease in VO2, mainly if the thermogenic response is blunted (36). In the present study, a drop in VO2 was observed 2 h after injection of the higher NO-blocker dose.

A review of the literature reveals contradictory effects of hypercapnia on VO2. Numerous factors such as intrinsic species differences may contribute to the variability in the metabolic effects of CO2 inhalation. Some investigators have observed an increase in both VO2 and VE, the former being commonly attributed to the energetic cost of hyperventilation, for example in ponies (14). In the present study hypercania had no effect on VO2 in rats, as also observed by Saiki and Mortola (31), who detected only a small but not significant trend for VO2 to increase with 2 and 5% CO2 inhalation. Finally, cats show a large drop in VO2 during 4% CO2 breathing at room temperature (30). Different energetic costs of hyperventilation may complicate the interpretation of such results. With this fact taken into consideration, hypercapnia might have reduced the metabolic rate, but this could not be measured because of the hyperventilation response. Thus CO2 exposure had no effect on VO2 in rats after saline or L-NNA, at the two lower doses. However, the drop in VO2 in the subgroup injected with the higher dose of L-NNA was recovered during CO2 exposure, possibly because of the hyperventilation response.

Effects of L-NNA on the Interaction Between Hypothermia and Hyperventilation During Hypercapnia

The present study indicates that the responses elicited by hypercapnia, hyperventilation, and hypothermia do not share NO as a common mediator because no interaction exists between the effects of L-NNA on hypercapnia-induced hyperventilation and hypothermia simultaneously. NOS inhibition did not change the ventilatory drive to hypercapnia, even though it caused a drop in Tb. However, the L-arginine-NO pathway participates in normal respiratory function and thermoregulation. Several studies have been conducted to determine whether changes in Tb alter the ventilatory response to changes in inspired CO2 levels, but in homeotherms the methodology always seems to be a problem, yielding divergent results. Olievier et al. (28), using a Tb range of 34-40°C in anesthetized cats, concluded that Tb had no important modifying effects on the response to CO2. However, anesthetics impair the homeostatic mechanisms regulating Tb (21), and exposure to cold affects heat production and heat loss mechanisms but does not establish a lower set-point value of Tb. Maskrey (21) reported that the effect of cooling on the response to breathing CO2-enriched air was to raise VE in awake rats. He used an abdominal heat exchanger to cause hypothermia, which again does not affect the set point for Tb. Ectothermic animals seem to be a better model for studying the effect of Tb on the hypercapnic drive to breathe, but data in the literature also show divergent results. In the toad Bufo paracnemis, decreases in Tb elicit a reduced hypercapnic drive to breathe (4). In contrast, Jackson et al. (13) demonstrated that VE in Pseudemys turtles displays a similar sensitivity to increases in inspired CO2 at 10, 20, and 30°C. The present study, conducted in conscious rats and at ambient temperature, shows that a modest but significant drop in Tb, caused by NOS blockade, which seems to interfere with the set point for Tb, had no effect on the hypercapnic drive to breathe.

    ACKNOWLEDGEMENTS

We thank Dr. Augusto S. Abe for use of equipment.

    FOOTNOTES

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Científico e Tecnológico. R. C. H. Barros was the recipient of a FAPESP postgraduate scholarship.

Address for reprint requests: L. G. S. Branco, Departamento de Fisiologia, Faculdade de Odontologia de Ribeirão Preto/USP, 14040-904 Ribeirão Preto, SP, Brazil (E-mail: lgsbranc{at}usp.br).

Received 10 December 1997; accepted in final form 27 April 1998.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Barros, R. C. H., E. S. Oliveira, P. L. B. Rocha, and L. G. S. Branco. Respiratory and metabolic responses of the spiny rats Proechimys yonenagae and P. iheringi to CO2. Respir. Physiol. 111: 223-231, 1998[Medline].

2.   Bartlett, D., Jr., and S. M. Tenney. Control of breathing in experimental anemia. Respir. Physiol. 10: 384-395, 1970[Medline].

3.   Branco, L. G. S., E. C. Cárnio, and R. C. H. Barros. Role of nitric oxide pathway in hypoxia-induced hypothermia of rats. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R967-R971, 1997[Abstract/Free Full Text].

4.   Branco, L. G. S., M. L. Glass, T. Wang, and A. Hoffmann. Temperature and central chemoreceptor drive to ventilation in toad (Bufo paracnemis). Respir. Physiol. 93: 337-346, 1993[Medline].

5.   Branco, L. G. S., and S. C. Wood. Role of central chemoreceptors in behavioral thermoregulation of the toad, Bufo marinus. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1483-R1487, 1994[Abstract/Free Full Text].

6.   Chungh, D. K., M. Katayama, A. Mokashi, D. E. Bebout, D. K. Ray, and S. Lahiri. Nitric oxide-related inhibition of carotid chemosensory nerve activity in the cat. Respir. Physiol. 97: 147-156, 1994[Medline].

7.   De Luca, B., M. Monda, and A. Sullo. Changes in eating behavior and thermoregulation activity following inhibition of nitric oxide formation. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R1533-R1538, 1995[Abstract/Free Full Text].

8.   Dun, N. J., S. L. Dun, and U. Förstermann. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience 59: 429-445, 1994[Medline].

9.   Furchgott, R. F., and J. V. Zawadzki. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcoline. Nature 288: 373-373, 1980[Medline].

10.   Gautier, H., M. Bonora, and H. C. Trinh. Ventilatory and metabolic response to cold and CO2 in intact and carotid body-denervated awake rats. J. Appl. Physiol. 75: 2570-2579, 1993[Abstract/Free Full Text].

11.   Gourine, A. V. Pharmacological evidence that nitric oxide can act as an endogenous antipyretic factor in endotoxin-induced fever in rabbits. Gen. Pharmacol. 26: 835-841, 1995[Medline].

12.   Gozal, D., J. E. Torres, Y. M. Gozal, and S. M. Littwin. Effect of nitric oxide synthase inhibition on cardiorespiratory responses in the conscious rat. J. Appl. Physiol. 81: 2068-2077, 1996[Abstract/Free Full Text].

13.   Jackson, D. C., S. E. Palmer, and W. L. Meadow. The effects of temperature and carbon dioxide breathing on ventilation and acid-base status of turtles. Respir. Physiol. 20: 131-146, 1974[Medline].

14.   Kaminski, R. P., H. V. Forster, G. E. Bisgard, L. G. Pan, S. M. Dorsey, and B. J. Barber. Effects of altered ambient temperature on metabolic rate during CO2 inhalation. J. Appl. Physiol. 58: 1592-1596, 1985[Abstract/Free Full Text].

15.   Kinkead, R. Episodic breathing in frogs: converging hypotheses on neural control of respiration in air breathing vertebrates. Am. Zool. 37: 31-40, 1997.

16.   Kuhnen, G., B. Wloch, and W. Wünnenberg. Effects of acute hypoxia and/or hypercapnia on body temperatures and cold induced thermogenesis in the golden hamster. J. Therm. Biol. 12: 103-107, 1987.

17.   Lai, Y. L., J. E. Lamm, and J. Hilderbrandt. Ventilation during prolonged hypercapnia in the rat. J. Appl. Physiol. 51: 78-83, 1981[Abstract/Free Full Text].

18.   Ling, L., D. R. Karius, R. R. Fiscus, and D. F. Speck. Endogenous nitric oxide required for an integrative respiratory function in the cat brain. J. Neurophysiol. 68: 1910-1912, 1992[Abstract/Free Full Text].

19.   Ma, S., F. M. Abboud, and R. B. Felder. Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarii. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R487-R491, 1995[Abstract/Free Full Text].

20.   Malan, A. Ventilation measured by body plethysmography in hibernating mammals and in poikilotherms. Respir. Physiol. 17: 32-44, 1973[Medline].

21.   Maskrey, M. Body temperature effects on hypoxic and hypercapnic responses in awake rats. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R492-R498, 1990[Abstract/Free Full Text].

22.   Mills, P. C., D. J. Marlin, C. M. Scott, and N. C. Smith. Nitric oxide and thermoregulation during exercise in the horse. J. Appl. Physiol. 82: 1035-1039, 1997[Abstract/Free Full Text].

23.   Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991[Medline].

24.   Morita, T., K. Konaka, Y. Kawasaki, F. Kawai, M. Kanamori, and H. Mitsuda. Effects of moderate hypercapnia on hypothermia induced by cold He-O2 in rats. Comp. Biochem. Physiol. A Physiol. 104: 215-218, 1993.

25.   Nagashima, T., H. Ohinata, and A. Kuroshima. Involvement of nitric oxide in noradrenaline-induced increase in blood-flow through brown adipose tissue. Life Sci. 54: 17-25, 1994[Medline].

26.   Nattie, E. E., and A. H. Li. Rat retrotrapezoid nucleus iono- and metabotropic glutamate receptors and the control of breathing. J. Appl. Physiol. 78: 153-163, 1995[Abstract/Free Full Text].

27.   Ogawa, H., A. Mizysawa, Y. Kikuchi, W. Hida, H. Miki, and K. Shirato. Nitric oxide as retrograde messenger in the nucleus tractus solitarii of rats during hypoxia. J. Physiol. (Lond.) 486: 494-504, 1995.

28.   Olievier, C. N., A. Berkenbosch, and J. de Goede. Effect of temperature on ventilatory response curve to carbon dioxide in anesthetized cats. Respir. Physiol. 47: 365-377, 1982[Medline].

29.   Pappenheimer, J. R., V. Fencl, S. R. Heisey, and D. Held. Role of cerebral fluids in control of respiration as studied in unanesthetized goats. Am. J. Physiol. 208: 436-450, 1965.

30.   Sachdeva, U., and D. B. Jennings. Effects of hypercapnia on metabolism, temperature, and ventilation during heat and fever. J. Appl. Physiol. 76: 1285-1293, 1994[Abstract/Free Full Text].

31.   Saiki, C., and J. P. Mortola. Effect of CO2 on the metabolic and ventilatory responses to ambient temperature in conscious adult and newborn rats. J. Physiol. (Lond.) 491: 261-269, 1996[Medline].

32.   Tamaki, Y., and T. Nakayam. Effects of air constituents on thermosensitivities of preoptic neurons: hypoxia versus hypercapnia. Pflügers Arch. 409: 1-6, 1987[Medline].

33.   Taylor, W. F., and V. S. Bishop. A role for nitric oxide in active thermoregulatory vasodilation. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1355-H1359, 1993[Abstract/Free Full Text].

34.   Teppema, L., A. Berkenbosch, and C. Olievier. Effect of Nomega -nitro-L-arginine on ventilatory response to hypercapnia in anesthetized cats. J. Appl. Physiol. 82: 292-297, 1997[Abstract/Free Full Text].

35.   Traystman, R. J., L. E. Moore, M. A. Helfaer, S. Davis, K. Banasiak, M. Williams, and P. D. Hurn. Nitro-L-arginine analogues: dose- and time-related nitric oxide synthase inhibition in brain. Stroke 26: 864-869, 1995[Abstract/Free Full Text].

36.   Wood, S. C. Interaction between hypoxia and hypothermia. Annu. Rev. Physiol. 53: 71-85, 1991[Medline].


J APPL PHYSIOL 85(3):967-972
8570-7587/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
J. Physiol.Home page
M. P. Walsh and J. M. Marshall
The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide
J. Physiol., August 15, 2006; 575(1): 263 - 275.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
J. Choi, L. A. Hoffman, G. W. Rodway, and J. M. Sethi
Markers of lung disease in exhaled breath: nitric oxide.
Biol Res Nurs, April 1, 2006; 7(4): 241 - 255.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
E. R. Price, F. Han, T. E. Dick, and K. P. Strohl
7-Nitroindazole and posthypoxic ventilatory behavior in the A/J and C57BL/6J mouse strains
J Appl Physiol, September 1, 2003; 95(3): 1097 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Subramanian, B. Erokwu, F. Han, T. E. Dick, and K. P. Strohl
L-NAME differentially alters ventilatory behavior in Sprague-Dawley and Brown Norway rats
J Appl Physiol, September 1, 2002; 93(3): 984 - 989.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. B. Harris, R. J. A. Wilson, K. Vasilakos, B. E. Taylor, and J. E. Remmers
Central respiratory activity of the tadpole in vitro brain stem is modulated diversely by nitric oxide
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R417 - R428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. H. Gargaglioni and L. G. S. Branco
Effect of nitric oxide in the nucleus isthmi on the hypoxic and hypercarbic drive to breathing of toads
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R338 - R345.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. A. Steiner, E. C. Carnio, and L. G. S. Branco
Role of neuronal nitric oxide synthase in hypoxia-induced anapyrexia in rats
J Appl Physiol, September 1, 2000; 89(3): 1131 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. G. S. Branco, A. A. Steiner, G. J. Tattersall, and S. C. Wood
Role of adenosine in the hypoxia-induced hypothermia of toads
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R196 - R201.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. D. Kline, T. Yang, D. R. D. Premkumar, A. J. Thomas, and N. R. Prabhakar
Blunted respiratory responses to hypoxia in mutant mice deficient in nitric oxide synthase-3
J Appl Physiol, April 1, 2000; 88(4): 1496 - 1508.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. C. Almeida, E. C. Carnio, and L. G. S. Branco
Role of nitric oxide in hypoxia inhibition of fever
J Appl Physiol, December 1, 1999; 87(6): 2186 - 2190.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Gautier and C. Murariu
Role of nitric oxide in hypoxic hypometabolism in rats
J Appl Physiol, July 1, 1999; 87(1): 104 - 110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. A. Steiner, E. C. Carnio, J. Antunes-Rodrigues, and L. G. S. Branco
Role of nitric oxide in systemic vasopressin-induced hypothermia
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R937 - R941.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barros, R. C. H.
Right arrow Articles by Branco, L. G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barros, R. C. H.
Right arrow Articles by Branco, L. G. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online